{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-24-002647","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.756785+00:00","generated_at":"2026-05-31T09:00:59.796808+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeward Q2 2024 revenue $6.7M (+400% YoY); net loss $0.50/shr, guidance reaffirmed","bullets":["Revenue of $6.7M, up from $1.3M in Q2 2023; ReWalk historical product revenue rose 131%.","Net loss of $4.3M ($0.50/shr) vs. $4.6M ($0.55/shr) a year ago; adjusted net loss $3.6M ($0.42/shr).","Record 20 ReWalk systems placed; Medicare claims from prior quarters beginning to be paid.","Cash $15.1M with no debt; FY 2024 revenue guidance maintained at $28M-$32M.","Launched NEO anti-gravity treadmill; FDA submission for 7th-gen ReWalk completed in June."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-24-002647","json":"https://secwatch.observer/filing/0001178913-24-002647.json","markdown":"https://secwatch.observer/filing/0001178913-24-002647.md","text":"https://secwatch.observer/filing/0001178913-24-002647.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891324002647/0001178913-24-002647-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891324002647/zk2431866.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:00:59.796808+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}